Bupropion as Add-On Strategy in Difficult-to-Treat Bipolar Depressive Patients

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Neuropsychobiology

• Publication date

  2002-03-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000049259PMID 11893875
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bipolar depression: pharmacotherapy and related therapeutic strategies.

  2000cited by this paper
• The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000.

  2000cited by this paper
• Mania with Bupropion: A Dose-Related Phenomenon?

  2000cited by this paper
• A double-blind study comparing idazoxan and bupropion in bipolar depressed patients.

  1999cited by this paper
• The evolving bipolar spectrum. Prototypes I, II, III, and IV.

  1999cited by this paper
• Use of bupropion with SRIs and venlafaxine

  1998cited by this paper
• Strategies for Managing Depression Complicated by Bipolar Disorder, Suicidal Ideation, or Psychotic Features

  1996cited by this paper
• A double-blind trial of bupropion versus desipramine for bipolar depression.

  1994cited by this paper
• Antidepressant-associated mania: a controlled comparison with spontaneous mania.

  1994cited by this paper
• Depressive mania: response of residual depression to bupropion.

  1994cited by this paper
• Bupropion and secondary mania. Is there a relationship?

  1993cited by this paper
• Bupropion in the treatment of bipolar disorders: the same old story?

  1992cited by this paper
• Bupropion as a promising approach to rapid cycling bipolar II patients.

  1990cited by this paper
• Bupropion in the long-term treatment of cyclic mood disorders: mood stabilizing effects.

  1985cited by this paper
• Bupropion's prophylactic efficacy in bipolar affective illness.

  1983cited by this paper
• A New Depression Scale Designed to be Sensitive to Change

  1979cited by this paper

• Bupropion Treatment for Stimulant Withdrawal in a Patient With Substance Use Disorder and Unspecified Bipolar Disorder

  2023cites this paper
• Wie wirken Antidepressiva? Weil sie einen Serotoninmangel im Gehirn ausgleichen?

  2023cites this paper
• The use of modern dopamine partial agonists in bipolar depression: is the evidence sound?

  2022cites this paper
• Bipolar disorder.

  2021cites this paper
• Verlauf und Therapie bipolarer Störungen

  2021cites this paper
• Transient effects of multi‐infusion ketamine augmentation on treatment‐resistant depressive symptoms in patients with treatment‐resistant bipolar depression – An open‐label three‐week pilot study

  2020cites this paper
• The CINP Guidelines on the Definition and Evidence-Based Interventions for Treatment-Resistant Bipolar Disorder

  2019cites this paper
• Evaluating the efficacy and safety of antidepressants in patients with bipolar disorder

  2019cites this paper
• Bupropion Maintenance Treatment in Refractory Bipolar Depression: A Case Report

  2017cites this paper
• Diagnostik und Therapie depressiver Störungen

  2017influential citation
• Diagnostik und Therapie depressiver Störungen

  2017cites this paper
• Significant Treatment Effect of Bupropion in Patients With Bipolar Disorder but Similar Phase-Shifting Rate as Other Antidepressants

  2016cites this paper
• Pharmacological Approaches for Treatment-resistant Bipolar Disorder

  2015cites this paper
• Tedaviye Dirençli Bipolar Bozukluk Treatment Resistant Bipolar Disorder

  2015cites this paper
• Clozapine for treatment‐resistant bipolar disorder: a systematic review

  2015cites this paper
• Options for Pharmacological Treatment of Refractory Bipolar Depression

  2014influential citation
• Augmentation of venlafaxine with bupropion: risks associated with a triple monoamine reuptake inhibition approach to partially responsive depression.

  2013cites this paper
• Assessing the Roles of Stimulants/Stimulant-like Drugs and Dopamine-agonists in the Treatment of Bipolar Depression

  2013cites this paper
• Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study

  2013cites this paper
• Augmentative dopaminergic interventions for treatment-resistant bipolar depression: a focus on dopamine agonists and stimulants

  2013cites this paper
• Assessing efficacy/effectiveness and safety/tolerability profiles of adjunctive pramipexole in bipolar depression: acute versus long-term data

  2013cites this paper
• İki Uçlu Depresyonun Farmakolojik Tedavisinde Yenilikler

  2013cites this paper
• Evidence‐based options for treatment‐resistant adult bipolar disorder patients

  2012cites this paper
• COMT polymorphisms as predictors of cognitive dysfunction during manic and mixed episodes in bipolar I disorder

  2012cites this paper
• Dilated and Unreactive Pupils and Burst-Suppression on Electroencephalography due to Buproprion Overdose

  2012cites this paper
• Einsatz von Bupropion bei älteren Patienten

  2011cites this paper
• Efficacy of Bupropion XR in Treatment-Resistant Elderly Patients: A Case Series Study

  2011cites this paper
• Plasma level monitoring of psychotropics and anticonvulsants Introduction

  2009cites this paper
• Computer‐Based De Novo Design, Synthesis, and Evaluation of Boronic Acid‐Based Artificial Receptors for Selective Recognition of Dopamine

  2008cites this paper
• Korean Medication Algorithm for Bipolar Disorder 2006(VI): Comparisons with Other Treatment Guidelines

  2008cites this paper
• Dans le trouble de l ’ humeur bipolaire , on admet aujourd ’ hui que le degré de morbidité et les enjeux théra-peutiques qui y sont associés tiennent davantage aux épi-sodes dépressifs qu ’ aux épisodes maniaques

  2007cites this paper
• Atypical antipsychotics in bipolar depression: neurobiological basis and clinical implications.

  2007cites this paper
• Melancholia: The Diagnosis, Pathophysiology and Treatment of Depressive Illness

  2006cites this paper
• Traitement pharmacologique des dépressions bipolaires: Bipolar depression : a review of current therapeutic strategies

  2006cites this paper
• Antidepressant-like effects of Trichilia catigua (Catuaba) extract: evidence for dopaminergic-mediated mechanisms

  2005cites this paper
• Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.

  2005cites this paper
• Pediatric Bupropion-Induced Serum Sicknesslike Reaction

  2004cites this paper
• Central monoamines and their role in major depression.

  2004cites this paper
• A review of acute treatments for bipolar depression

  2004cites this paper
• Antidepressant-induced mania: an overview of current controversies.

  2003cites this paper
• Zonisamide pour le traitement de l'obésité

  2003cites this paper
• Avoiding Drug-Induced Switching in Patients with Bipolar Depression

  2003cites this paper